Page last updated: 2024-08-22

trimetazidine and Syndrome

trimetazidine has been researched along with Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Drobotia, NV; Eroshenko, OL; Kastanaian, AA; Kazarian, NB; Nelasov, NIu	1
Fragakis, N; Giannoglou, G; Katsaris, G; Labrou, A; Louridas, G; Zioutas, D	1

Trials

2 trial(s) available for trimetazidine and Syndrome

Article	Year
[Effect of acetyl-CoA C-acyltransferase inhibitor trimetazidine on parameters of global and local systolic and diastolic functions of left ventricular myocardium in patients with combined postinfarction ischemic syndrome]. Kardiologiia, 2003, Volume: 43, Issue:9 Topics: Acetyl-CoA C-Acyltransferase; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Syndrome; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left	2003
Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007, Volume: 7, Issue:2 Topics: Acute Disease; Administration, Oral; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Creatine Kinase, MB Form; Echocardiography; Female; Heart Ventricles; Humans; Hypokinesia; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardial Revascularization; Premedication; Syndrome; Trimetazidine; Troponin I; Vasodilator Agents; Ventricular Dysfunction, Left	2007

Article

Year

[Effect of acetyl-CoA C-acyltransferase inhibitor trimetazidine on parameters of global and local systolic and diastolic functions of left ventricular myocardium in patients with combined postinfarction ischemic syndrome].

Kardiologiia, 2003, Volume: 43, Issue:9

Topics: Acetyl-CoA C-Acyltransferase; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Syndrome; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left

2003

Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007, Volume: 7, Issue:2

Topics: Acute Disease; Administration, Oral; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Creatine Kinase, MB Form; Echocardiography; Female; Heart Ventricles; Humans; Hypokinesia; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardial Revascularization; Premedication; Syndrome; Trimetazidine; Troponin I; Vasodilator Agents; Ventricular Dysfunction, Left

2007